All News

The chief of medical oncology and hematology at Bryn Mawr Hospital and associate principal investigator for Main Line Health's NCI Community Oncology Research Program discusses therapeutic advances along with ongoing challenges in enrolling patients with small cell lung cancer (SCLC) in clinical trials.

Ruxolitinib is increasingly being used in patients with graft-vs-host-disease (GVHD); a recent study found a link with transplant-associated thrombotic microangiopathy (TA-TMA) in patients with GVHD treated with the therapy.

Tonya Winders, MBA, CEO and president of the Allergy & Asthma Network, lists the major current issues with current asthma care guidelines at the European Respiratory Society (ERS) International Congress 2021.

There are many conveniences to remote consultations, but they should be weighed against the disadvantages, said Hilary Pinnock, MD, professor and personal chair of primary care respiratory medicine for the Deanery of Molecular, Genetic and Population Health Sciences at the University of Edinburgh in Scotland.

Michael E. Wechsler, MD, a pulmonologist at National Jewish Health, explains the role that eosinophils play in everyday health and disease development.

At ERS 2021, Ilona Jaspers, PhD, discusses some of the major health concerns associated with teenagers and young adults vaping.

Using the argument that regularly taking medication is a great way to earn parents' trust is a great tactic to encourage children and teenagers to remain adherent to their asthma therapies, said William "Andy" Nish, MD, an allergist and immunologist in Georgia.

Being a full-service dermatology practice helps make patients' lives easier when they have skin cancer, explained Todd Schlesinger, MD, FAAD, director, Dermatology and Laser Center of Charleston and Clinical Research Center of the Carolinas.

For patients with diffuse large B-cell lymphoma (DLBCL), PET/CT scans conducted in the first cycle of salvage therapy can predict for response, according to a study.

The study, conducted in Spain, sought to determine the factors that created a higher risk of death from acute exacerbations of chronic obstructive pulmonary disease (COPD) in primary care.

Hepatocellular carcinoma (HCC) is challenging to diagnose and has an evolving treatment landscape, which makes a multidisciplinary approach to care important to ensure high-quality care and the best patient outcomes.

A review looks at techniques to monitor minimal residual disease (MRD) in patients with multiple myeloma (MM).

Gaucher disease is a rare metabolic condition that causes a fatty substance to build up in the organs and bones. Patients can suffer liver enlargement, anemia, and reduced platelets; they experience fatigue, bone infarctions, and permanent disability or death.

Results of the SAFINONMOTOR open-label study found that safinamide was safe and effective in improving pain of patients with Parkinson disease at 6 months.

Sodium-glucose co-transporter 2 (SGLT2) inhibitors have been shown to both lower blood pressure and promote weight loss, and they act rather subtly, stated Rudolf de Boer, MD, PhD, clinical cardiologist and professor of translational cardiology, University Medical Center Groningen, the Netherlands.

The murine study, which assessed the combination of foretinib and an anti–PD-1 antibody, found that the regimen enhanced antitumor activity, offering promise in a cancer that has seen less success with immunotherapies than others.

Investigators identified serial liquid biopsy as an effective tool for identifying mutational changes of RAS genes in patients with metastatic colorectal cancer (mCRC) who have undergone antiangiogenic therapy.

New CDC data show an increase in some health care–associated infections during COVID-19.

Polypharmacy may be raising the risk of inappropriate medication use, and avoiding this is crucial.

It is the third set of warnings for certain Janus kinase (JAK) inhibitors due to the risk of heart attack or stroke, cancer, blood clots, and death.

Research shows how socioeconomic status can affect prognosis among patients with hepatocellular carcinoma (HCC).

Members of Congress ask the FDA for documents relating to Aduhelm's controversial approval; outside experts will advise the FDA on booster shots; nursing shortages intensify.

The product, lonapegsomatropin, is a sustained-release formulation and could replace daily injections.

Coverage of our peer-reviewed research and news reporting in the health care and mainstream press.

Neal Dave, PharmD, the executive director of pharmacy at Texas Oncology, discussed physician anticipation for the first biosimilars for programmed death (PD)-1 inhibitors.

Even though respondents did not know very much about spinal muscular atrophy, the survey showed that most were in favor of newborn screening.

STEP findings build on those from the SPRINT trial, seemingly confirming that intensive treatment for hypertension can reduce the risk of serious adverse cardiovascular (CV) outcomes. However, there was no significant benefit toward risk for all-cause and CV-related mortality.

Native American and Black youth aged 10 to 19 years had the highest incidence of type 2 diabetes overall.